Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Myeloid, Chronic-Phase (CML-CP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04971226
What this trial is testing

Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

Who this might be right for
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals 405
Early research (Phase 1)Study completedNCT01220648
What this trial is testing

Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 4
Early research (Phase 1)Study completedNCT01456676
What this trial is testing

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

Who this might be right for
Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 11
Not applicableLooking for participantsNCT07549516
What this trial is testing

A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

Who this might be right for
Leukemia, Chronic Myeloid
Novartis Pharmaceuticals 380
Early research (Phase 1)Looking for participantsNCT07651878
What this trial is testing

Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

Who this might be right for
CML (Chronic Myelogenous Leukemia)
Mendus 24
Not applicableUnknownNCT04681820
What this trial is testing

Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib

Who this might be right for
CML-CP; Mutation;Suboptimal Response or Failure in TKI
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200
Testing effectiveness (Phase 2)UnknownNCT03883087
What this trial is testing

A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
Ascentage Pharma Group Inc. 41
Testing effectiveness (Phase 2)Study completedNCT00042016
What this trial is testing

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Who this might be right for
Chronic Myelogenous Leukemia
Astex Pharmaceuticals, Inc. 40
Large-scale testing (Phase 3)Study completedNCT03106779
What this trial is testing

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 233
Post-approval studies (Phase 4)Study completedNCT06427811
What this trial is testing

Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation

Who this might be right for
Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Novartis Pharmaceuticals 85
Not applicableStudy completedNCT06516029
What this trial is testing

Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With Asciminib

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
Novartis 111
Post-approval studies (Phase 4)Study completedNCT04925141
What this trial is testing

Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP)

Who this might be right for
Chronic Myelogenous Leukemia - Chronic Phase
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 62
Not applicableStudy completedNCT02348957
What this trial is testing

Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib

Who this might be right for
Myeloid Leukemia, Chronic, Chronic-Phase
Onco Medical Consult GmbH 223
Testing effectiveness (Phase 2)Study completedNCT01602952
What this trial is testing

Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI

Who this might be right for
LeukemiaLeukemia, MyeloidLeukemia, Myelogenous, Chronic, BCR-ABL Positive+2 more
Il-Yang Pharm. Co., Ltd. 85
Testing effectiveness (Phase 2)Study completedNCT04795427
What this trial is testing

Study of Efficacy and Safety of CML-CP Patients Treated With Asciminib Versus Best Available Therapy, Previously Treated With 2 or More Tyrosine Kinase Inhibitors

Who this might be right for
Leukemia, Chronic Myelogenous
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Study completedNCT00809211
What this trial is testing

Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Cancer Trials Ireland 40
Large-scale testing (Phase 3)Study completedNCT04948333
What this trial is testing

Asciminib Treatment Optimization in ≥ 3rd Line CML-CP

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 199
Large-scale testing (Phase 3)Study completedNCT02204644
What this trial is testing

The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML

Who this might be right for
CML, CML-CP,MMR,TKI
Jiangsu Hansoh Pharmaceutical Co., Ltd. 400
Not applicableLooking for participantsNCT06684964
What this trial is testing

RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)

Who this might be right for
Chronic Myelogenous Leukemia in Chronic Phase
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT01850004
What this trial is testing

Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response

Who this might be right for
Chronic Phase Chronic Myeloid Leukemia
Bristol-Myers Squibb 84
Next Page